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Abstract Purpose We aim at developing a framework
for the validation of a subject-specific multi-physics model
of liver tumor radiofrequency ablation (RFA).
Methods The RFA computation becomes subject-specific
after several levels of personalization: geometrical and
biophysical (hemodynamics, heat transfer and an ex-
tended cellular necrosis model). We present a compre-
hensive experimental set-up combining multi-modal, pre-
and post-operative anatomical and functional images,
as well as the interventional monitoring of intra-operative
signals: the temperature and delivered power.
Results To exploit this data set, an efficient processing
pipeline is introduced, which copes with image noise,
variable resolution and anisotropy. The validation study
includes twelve ablations from five healthy pig livers: a
mean point-to-mesh error between predicted and actual
ablation extent of 5.3 ± 3.6 mm is achieved.
Conclusion This enables an end-to-end pre-clinical val-
idation framework that considers the available data set.
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1 Introduction
During liver tumor radiofrequency ablation (RFA), the
clinician inserts a probe percutaneously or during open
surgery in the liver parenchyma, visualization of the
thermal induced necrosis progress is then unavailable.
Tailoring the heating protocol to the individual pa-
tient is thus challenging due to inter-subject variability
in tissue characteristics [1], the heterogeneous cooling
effect of large neighboring vessels [2], porous circula-
tion [3] and blood coagulation [4]. As a result, subject-
specific computational modelling of RFA could improve
the planning of the procedure and provide additional
guidance during the intervention for a given patient.
More specifically, such models could potentially esti-
mate in-vivo temperatures, calculate the size, the shape
and the location of the necrotic area, given the position
and settings of the ablation probe in the liver. Thus
they could help the clinician in deciding where to place
the heating probe and for how long heating must be
applied in order to fully ablate the lesion. For instance,
the probe placement has been optimized in [5] by using
segmentation masks and the exploration of the set of
pareto-efficient solutions.
Several approaches have been developed to describe
and model RFA of liver tumors. They differ in their
choice of the biophysical phenomena considered and
the type of experimental data used to design and val-
idate them. All simulations are based on the bioheat
equation considering a cooling effect that is either ne-
glected [6], spread all over the liver [4] or considering
the hepatic vasculature [6–9]. The bioheat equation is
simulated based on the most common discretization
method: the Finite Element Method (FEM) [6,7,10] or
the Lattice Boltzmann Method (LBM) [9,11]. Other
authors propose a simplified model using a weighted
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distance-based method [5,12] to approximate the abla-
tion zone in real-time using graphics processing units
(GPU), but the analysis of the effect of an approx-
imation instead of the complex numerical simulation
has not been done yet. The cooling effect due to ve-
nous flow in the parenchyma is also considered in [8,
9], whereas it is not the case for arterial flow. How-
ever hepatic veins, portal vein and the hepatic arter-
ies have significantly different effects on the thermal-
induced lesion [13], which might be due to the differ-
ence in their flow velocities, profile and microvascular
branching pattern. While the Pennes model [14] ac-
counts for parenchymal perfusion in a simplified man-
ner, by assuming a uniform distribution throughout
the tissue, a more comprehensive model is needed to
evaluate its effect. Hepatic perfusion can be simulated
precisely based on micro-CT [15], but we propose an
elaborated model based on vessels segmented from CT
images, which does not require mesh generation, sim-
plify the setting of boundary conditions and reduce the
computational time compared to Darcy flow model for
example [9].
Few authors [7–9] propose to simulate RFA on real-
istic subject-specific geometries extracted from images
and only [11] has personalized biophysical parameters
on patient data to minimize the discrepancy between
simulated and measured necrotic regions. Indeed, pa-
rameters in the literature often come from tissue ex-
periments on different species ex-vivo [1], and their ap-
plication to human is not granted.
Up to now, the comparison between simulated and
measured necrotic regions has been used by several au-
thors [7–9] as the main criteria of success in calculating
the effect of RFA on abdominal tumors, for either model
validation or personalization. However, the necrosis of
tissue is the resultant of several combined physical phe-
nomena, mainly the heat transfer and cell death mech-
anisms, meaning that a given ablated region may be
explained by several combinations of parameters. In ad-
dition to this identifiability issue, the size of the tumor
extent can only be known reliably from post-operative
imaging and its shape may be highly asymmetric [1],
which makes it difficult to eventually update the abla-
tion plan during the procedure. A method that relies
also on pre-operative or interventional data for valida-
tion or personalization is therefore required for RFA
models to be clinically useful. Those observations are
complementary information to the necrotic extent for
model evaluation.
Computational models of RFA depend on a large
number of different parameters, which depend mostly
on the patient, the temperature or the current state of
the tissue. They also have a high computationnal cost.
Understanding the observability of parameters is chal-
lenging with clinical data but is more feasible on pre-
clinical data in a more controlled environment. This ex-
tensive validation step is important prior to any trans-
lation into clinical settings. It is paramount because
the size and the location of the RFA lesion has to be
predictable and controllable for clinical applications. A
comprehensive understanding of detailed multi-physics
model is required first to simplify only the aspects that
are not needed, which could then enable model simpli-
fication and personalization, and eventually computa-
tional models of RFA can be helpful for interventional
guidance or therapy planning.
In this paper, a pre-clinical study for validation of
RFA model is introduced, based on pre-, intra- and
post-operative data (Sec. 2). We first present the data
analysis required before using the information from the
images into the model. Since our approach relies on
pre-clinical data of healthy pigs in a controlled environ-
ment, the validation leads to an increased confidence in
the computed information.
The computational model, implemented using LBM,
is personalized at different levels: the anatomy is es-
timated from Computed Tomography (CT) and blood
flow from Phase-Contrast MR imaging and invasive mea-
surements (Sec. 3). Heat transfer is computed according
to the bioheat equation, coupled with a novel cellular
necrosis model, equivalent to the one proposed in [16],
except that we do not assume a single forward rate coef-
ficient. A Computational Fluid Dynamics (CFD) solver
which incorporates a porous part to deal with the liver
parenchyma is also used. In Sec. 4, an evaluation of
each pre-processing step is performed first to highlight
the different sources of error. The model is evaluated
on twelve ablations from five healthy pigs, inside which
surrogate tumors have been implanted. Based on post-
operative images and measurements, we present suit-
able predictions of necrotic region extent, temperature
and power evolution. As we rely on a LBM implemen-
tation on GPU, a single simulation is faster than real
time, which allows us to adjust key biophysical param-
eters. Those key model parameters (heat conductivity
and heat capacity) are estimated from this pipeline by
minimizing the error between the computed power and
cooling temperature and the observed values. Sec. 6
concludes the paper.
This study extends our previous work [9] on a clin-
ical dataset of 10 patients. In this work, a novel cell
death model is proposed and the CFD solver used to
compute the blood flow is also new. We use a complete
patient-specific geometry including hepatic venous and
arterial circulation systems, the addition of patient-
specific boundary conditions acquired pre-operatively
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by imaging and invasive measurements. The estimation
of the main parameters of the model is performed au-
tomatically and the evaluation of the proposed model
is performed on a pre-clinical dataset of five pigs from
a comprehensive experimental set-up specially designed
for RFA model validation.
2 Pre-clinical Data Acquisition & Processing
A comprehensive animal experiment has been realized
specifically for model validation and parameter identifi-
cation. It includes several modalities at pre-, intra- and
post-operative stages. Fig. 1 illustrates the available
pre-clinical data (in blue), the different pre-processing
steps needed (in red, green and white) before perform-
ing the computation (in grey).
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Fig. 1 Pipeline presenting the available pre-clinical data in
blue, the pre-processing needed to use those data (segmenta-
tion in green, registration in red), the different computations
done and finally a possible personalization framework.
Surrogate tumors 
1 
Fig. 2 Two CT images of Pig 1. (Left) Before surrogate tu-
mor implantation; (Right) After surrogate tumor implanta-
tion.
2.1 Experimental Set-up
The present experimental study (No. 38.2014.01.063)
received approval from the local Ethical Committee on
Animal Experimentation. All animals used in the exper-
imental laboratory were managed according to French
laws for animal use and care and according to the direc-
tives of the European Community Council (2010/63/EU).
Pigs are considered as a relevant animal model as
their hepatic system is similar to the human one. Sev-
eral surrogate tumors (diameters < 3 cm) are inserted
on five swines to mimic the clinical workflow, where
the clinician has to insert the RFA probe targeting the
tumor and to choose its diameter depending on the tu-
mor size. They are implanted at various locations of the
liver (close to vessels or the Glisson capsule) under ul-
trasound (US) guidance (SIEMENS ACUSON S3000),
followed by the acquisition of pre-operative CT images
including portal, venous and arterial phases (SIEMENS
Somatom Definition A5) since it has been showed that
the large vessels play an important role in the shape of
the necrotic lesion [9]. The surrogate tumors are made
of a specific gel (a mix of biocompatible gelatin, alginate
and nanoparticles) which exhibits an hyper-intense sig-
nal in CT and MRI as illustrated in Fig. 2. We refer
to the different tumors as Pig n - m, for the mth tu-
mor inserted in the nth pig. A catheter is introduced
through the jugular vein to get the free and the wedge
pressure in a subhepatic vein and in the vena cava. An
MR-compatible RFA probe, the radiofrequency intersti-
tial tumor ablation (RITA) probe (StarBurst RFA, An-
gioDynamics; www.angiodynamics.com), is deployed at
2 cm of diameter (the diameter of the area defined by
the tips of the probe is 2 cm) under US guidance (Fig. 3)
next to the targeted surrogate tumor. An MR image
is then acquired to get the position of the probe in
the liver (SIEMENS Magnetom Aera 1.5T) and flow
data. The temperature and delivered power are mon-
itored (there are thermistors at the probe tips) and
recorded intra-operatively during and after the abla-
tion. Finally, to assess the extent of the necrotic areas,
a post-operative CT without contrast agent to limit
the radiation exposure for ethical reason), T2 or T1 +
gadolinium MRI are acquired two days after the abla-
tion [17–19]. Unfortunately, all the post-operative im-
ages were not systematically acquired. We would ac-
quire as many images as possible, but depending on the
pig condition, and/or the procedure duration (individ-
ual experimental changes), we were not able to acquire
all the images in every case (see supplementary ma-
terials for available images). Overall, pre-, intra- and
post-operative images are available, along with inter-
ventional device measurements (Fig. 1). To the best of
4 Chloé Audigier1,2 et al.
RFA probe 
liver 
Tips of the 
probe 
RFA 
probe 
tumor 
Fig. 3 (Left) Picture of the probe inside the pig liver; (Right)
U.S image of the probe next to the surrogate tumor. The
probe diameter is shown in red, the tumor diameter in green.
our knowledge, no such validation set-up has been re-
ported previously in the literature.
2.2 3D Modeling of the RFA Probe
The geometry of the probe deployed at 2 cm is ac-
quired from a CT image (resolution: 0.2x0.2x0.9 mm)
of the probe alone. A 3D mesh is then reconstructed
by thresholding the image intensity (Fig. 4, left), and
manually registered to the pre-operative CT using the
main axis of the probe and intra-operative MR data.
The manual rigid registration is done using Paraview 1
and is visually checked by an expert up to a rotation
along the probe axis. While the main axis is clearly
visible as well as three or four tips (depending on the
ablation considered), the MR resolution does not al-
low to distinguish between the nine tips of the probe
individually (Fig. 4, right).
Geometrical model  
of the RFA probe 
Tips of the probe 
Fig. 4 (Left) Mesh model of the probe with the 9 tips derived
from a CT image of the probe only; (Right) Anatomical MRI
with the MRI-compatible probe implanted in the liver. Four
tips are visible.
2.3 Data Pre-processing: Segmentation
As each structure of interest is needed as input of the
RFA computational model, the segmentation of patient
1 http://www.paraview.org/
Fig. 5 Segmentation of the liver in magenta, arterial vessels
in red, portal and hepatic networks in light blue and dark blue
respectively, surrogate tumors in dark green and gall bladder
in light green. (Left) Overlay of the segmented areas on pre-
operative CT image. (Right) Vessels and liver parenchyma.
images is a determinant task. From the pre-operative
CT data, the following anatomical and pathological re-
gions are segmented semi-automatically and meshed by
the tools of Visible Patient, Strasbourg, France [20]
(Fig. 5): parenchyma, hepatic veins, vena cava, por-
tal vein, hepatic arteries and all tumors. These regions
are then used to define the computational domain. The
meshes are rasterized and a multi-label mask image is
created to identify the different structures on a Carte-
sian grid of user-defined resolution. To define the com-
putational domain, a level set representation of the liver
without tumor and vessels is computed. Necrotic ar-
eas around the surrogate tumor gel are segmented and
meshed from the available post-operative CT or MR
data on which it is the most visible.
2.4 Data Pre-processing: CFD Computational Domain
Smooth Vessel Trees. The pre-operative images from
which the vessels are segmented have anisotropic res-
olution. To avoid unstable solution of the CFD solver,
smooth vessel trees have to be generated from the semi-
automatic segmentations. To this end, centerlines are
extracted from each vessel segmentation using VMTK 2
(Fig. 6, left). Along each branch of the centerline, the
mean radius is computed and the smooth vessel tree
is generated by overlaying cylinders having this mean
radius in a piecewise fashion (Fig. 6, right). All those
cylinders are rasterized on a single image.
Blood flow from Phase-Contrast MRI. The com-
putational model of RFA requires as inputs the blood
flow entering the vena cava, the portal vein and the
hepatic artery. Instead of fixing nominal values from
the literature, 2D+t Phase-Contrast MR images were
acquired pre-operatively before the probe implantation
in order to impose subject-specific values as boundary
conditions.
2 The Vascular Modeling Toolkit, www.vmtk.org.
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Fig. 6 (Left) Centerlines extraction from the vessel segmen-
tation. The segmentation gives non-smooth vessels due to the
anisotropy of input images. (Right) Smooth vessels generated
from the centerlines.
For each pig, several 2D+time sequences are ac-
quired at different time points (9 sequences on average,
min: 3, max: 17), for the reproducibility of data, and
also at different locations: at the inlet of the hepatic
artery, at the inlet of the portal vein and at the inlet
of the vena cava. Given one 2D+t sequence, the user
places a single seed in the vessel of interest in the first
image and then an automatic method is used to seg-
ment this vessel on each 2D slice (Fig. 7, right) [21,
22]. Using the vessel area defined by the segmentation,
the mean blood flow can be computed at each time. If
N 2D+t sequences are acquired at the same location
but at different time points, this is done N times and
the RMS of the mean of those N curves is used. As we
learned throughout the cases how to best acquire data,
we decided to use the measurements of Pig 5 for all the
other cases to cope with noise, non-reproducible and
non-coherent measures on the first four pigs. We assume
that the values will not vary much, which is reasonable
since all the pigs were healthy, of similar weight and age.
For Pig 5 (vena cava), the acquisition has been done at
3 different time points (N = 3). The RMS of the mean
of those three curves is used (Fig. 7, left black curve)
since numerical results have shown that pulsatile veloc-
ity profile in large blood vessels has little difference in
effect on the thermal lesion region of tissue compared
with uniform or parabolic velocity profile [23].
Pressure from Invasive Measurements. The com-
putational model of RFA requires also vena cava and
hepatic artery blood pressures as inputs (See arrows on
Fig. 9 for the locations where the boundary conditions
are applied). In order to impose subject-specific val-
ues as boundary conditions, these blood pressures have
been measured to avoid the use of nominal values from
the literature. The pressures at the outlet of the vena
cava and the hepatic artery were measured invasively
by catheter introduced through the jugular vein. The
same values (from Pig 5) are used as boundary condi-
tions in the five pigs, as it is the case for the blood flow
measurements.
Fig. 7 (Left) Velocity in the vena cava of Pig 5 from Phase-
Contrast MRI with respect to trigger time (all measures are
registered on the cardiac pulse). In cyan, the mean of different
measurements at different times (red, blue, green curves). The
RMS of this curve (black curve) is then used as boundary con-
ditions in the computation as ϕvcin. (Right) Phase-Contrast
MRI of Pig 5: the vena cava is segmented in green, the portal
vein in blue and the aorta in yellow.
Porosity Map. The porosity, defined as the fraction of
blood volume (Vb) over the total volume (Vt): ε = Vb/Vt,
has to be defined everywhere in the computational do-
main as it is an input of the CFD solver. The vessel
walls are defined as follow. The smooth vessel trees are
rasterized on a single image. On this image, we per-
form a 26-connexity dilation on the voxels of the ves-
sels to model the endothelium and avoid the flow to go
through the vessel wall. The extremities are detected
using the centerlines previously used and the porosity
at the extremities is set to the parenchyma porosity
value. Fig. 8 shows an example of porosity map. The
porosity value is 1 in the CT-visible vessels, 0.1 in the
parenchyma [8], modeled then as a porous medium. Ex-
periments have been performed to obtain a sufficiently
small porosity (0.04) in the vessel walls (impermeable
medium) to avoid the occurrence of shear stress on the
vessel walls (leakage) [11].
Fig. 8 (Left) The porosity map of Pig 1 created from the ves-
sels segmentation. The porosity is 1 in the vessels (in white),
0.04 in the endothelium (in black) and 0.1 in the parenchyma.
(Right) Zoom on the porosity map. The extremities of the ves-
sels are detected using the centerlines so that the blood flow
can go through the vessel.
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2.5 Data Pre-processing: Post-To-Pre Registration
Due to ethical reasons, CT with contrast agent could
not be acquired two days after intervention, making
accurate post- to pre-operative registration challeng-
ing. In order to compare the results of the computa-
tion with the ground truth given by the post-operative
images, registration of the post- to the pre-operative
image is performed. For each pig, the pre-operative im-
age (CT from different phases) does not necessarily be-
long to the same modality as the post-operative image
(CT or MRI (T2 or T1 + gad)) due to individual ex-
perimental changes. Moreover, the pigs are neither in
a similar position nor a similar condition, as they had
an empty stomach the day of the intervention, which
was not true two days after. Breathing has also an im-
portant impact on the shape of the liver. For those rea-
sons, we choose to register the post-operative meshes to
the pre-operative image instead of pure image-to-image
registration. From the semi-automatic segmentation of
the post-operative image, a tetrahedral mesh is gen-
erated using CGAL 3. From the segmentation of the
pre-operative image, a binary mask of the liver includ-
ing vessels and arteries is generated. Using the SOFA
framework 4, the post-operative mesh is deformed elas-
tically to match the intensity profile in the pre-operative
image using the Finite Element Method (FEM) and a
co-rotational model [24]. First-order implicit Euler time
integration is employed and the system of equation is
solved with the conjugate gradient algorithm. The com-
puted deformation field is then applied to the necrotic
surface mesh using a barycentric mapping between the
coordinates of the surface mesh and the tetrahedral
mesh (12 000 tetrahedra and 3000 nodes for Pig 5).
The registration is fast to perform, it took 178 seconds
on a Windows 7 laptop machine (Intel Core, 2.40 GHz,
8GB RAM, 8 CPUs) on average to register the post-
operative mesh to the pre-operative image.
3 Subject-Specific RFA Model
3.1 Liver Blood Flow Computation
Model Description. We want to get simultaneously
the blood flow in the large visible venous and arterial
vessels, as well as in the parenchyma. To that end, the
flow in the main vessels and in the parenchyma is simul-
taneously calculated using the generalized 3D incom-
pressible Navier-Stokes equation for fluid flow in porous
3 www.cgal.org.
4 www.sofa-framework.org.
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Fig. 9 (Left) Model of the hepatic circulatory system. Black
(resp. grey) arrows denote blood flow (resp. outlet pressures)
which are fixed as boundary conditions. (Right) Slice showing
the computed blood flow in the vessels and parenchyma. The
velocity magnitude is color-coded and the velocity vectors are
shown in black in the parenchyma.
media [25]. More precisely, writing v as the blood ve-
locity and p the pressure inside the liver, we solve:
∂v
∂t
+ v.∇v = −
1
ρb
∇p+
µ
ρb
∇2.v−
µ(1− ε)2
α2ε2
v︸ ︷︷ ︸
F
(1)
The last term of Eq. 1 is the added force F that mod-
els the total body force due to the presence of a porous
medium [26]. F depends on the porosity ε (fraction of
blood volume over the total volume) defined through a
porosity map (Fig. 8) as described in the previous sec-
tion. ρb is the blood density, µ, the shear viscosity of
the fluid and α2 an effective parameter.
Boundary Conditions. At the border of the liver, no
flux boundary conditions are used (Neumann) whereas
Dirichlet boundary conditions are applied at the inlets
and at the outlet of the large vessels: the portal vein,
vena cava and arterial inflows, ϕp, ϕvcin and ϕa are
given from pre-operative Phase-Contrast MR images
whereas the vena cava and arterial outlet pressures p0
and pa are given from catheterization. Fig. 9 illustrates
boundary conditions on a subject-specific geometry.
This method makes the boundary conditions simple
to treat: no boundary conditions are fixed on the ex-
tremities of the vessels inside the parenchyma thanks
to the use of the porosity map, contrary to [9].
Numerical Computation using LBM.
Eq. 1 is solved using the Lattice Boltzmann Method
(LBM) for fast computation on general purpose graph-
ics processing units (GPU). LBM has been developed
for CFD and is now a well-established discretization
method [27]. In this paper, LBM is used to compute the
porous and blood flow circulation in the liver. To this
end, an isotropic Cartesian grid with 19-connectivity
topology is used (D3Q19 scheme defined in Fig. 10, left)
as well as a Multiple-Relaxation-Time (MRT) model,
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Fig. 10 (Left) D3Q19 scheme used in the LBM computation
of the blood flow. (Right) Cell state evolution over time when
tissue is heated at 105◦C during 10 minutes.
for increased stability [28]. At position x for the edge
ei of the grid, the governing equation is:
f(x + ei∆x, t+∆t) = f(x, t) + A[f
eq(x, t)− f(x, t)] +∆tg(x, t)
feqi (x, t) = ωiρb[1 +
ei.v
cc2s
] gi(x, t) = ωiρb
ei.F
c2s
In this equation, f(x) = {fi(x)}i=0..18 is the vector of
distribution function with fi(x) being the probability
of finding a particle traveling along the edge ei of the
node x at a given time; c = ∆x/∆t; c2s = 1/3; ∆x is the
spacing; ω = {ωi}i=0..18 is the vector of weighting fac-
tors and A the MRT matrix. The fluid mass density and
velocity are computed from the LBM distributions as
ρb =
∑18
i=0 fi(x, t) and ρbv =
∑18
i=0 eifi(x, t)+ρbF∆t/2
and are updated at every node of the grid for every time
step ∆t.
3.2 Heat Transfer And Cellular Necrosis Models
Heat Transfer Model. The coupled bio-heat equation
describes how the heat flows from the probe through
the liver while taking into account the cooling effect of
the blood flow [29]. It depends on the patient-specific
anatomy (the segmentation process was presented in
Sec. 2.3) and on the blood flow inside the main vessels
and the parenchyma considered as a porous medium.
It has be shown [29] analytically and computation-
ally but in 1D that the coupled bio-heat equations can
be simplified into the Pennes model [14] in the case
of large vessels, and into the WK model in the case of
small vessels. Therefore, the temperature T is computed
by solving the following equations, either a reaction-
diffusion or an advection-diffusion equation:
ρtct
∂T
∂t
= Q+∇· (dt∇T )
{
+R(Tb0 − T )
−αvρbcbv ·∇T
(2)
where ρ, c, d are the density, heat capacity, con-
ductivity; subscripts t and b stand for tissue and blood
respectively. Q is the source term, αv, the advection
coefficient, R, the reaction coefficient (it corresponds
to H / (1-ε) from [8] ) and Tb0 the blood tempera-
ture (assumed constant) in large vessels. In this case,
the advection is the transport mechanism of the heat
by the blood due to its motion, whereas the diffusion
is the transport mechanism due to a temperature dif-
ference within a same region but without any motion.
The Pennes Model is solved in the large visible ves-
sels and the WK model in the liver parenchyma. Our
model includes the heat sink effect of all hepatic vessels
(veins and arteries) as well as the effect of the blood flow
within the parenchyma considered as a porous medium.
A weak coupling is considered: the blood flow has
an influence on the temperature distribution through
the advection term in the WK model and through the
reaction term in the Pennes model but the tempera-
ture does not affect the blood flow (coagulation is not
considered here), which allows us to speed up the cal-
culations since the blood flow distribution is computed
only once, at the beginning of the simulation, and is
run until a steady state is reached.
Cellular Necrosis Model. A three-state model [30]
is coupled with the bioheat equation to compute tis-
sue necrosis. Each cell has a probability to be either
undamaged (U), vulnerable (V) or necrotic (N). Those
probabilities vary with the temperature spatially and
temporally according to the following transition dia-
gram:
[U]
β(T )−−−→←−
γ
[V]
δ(T )−−−→ [N]
where β(T ) = β̄eT/Tk , δ(T ) = αβ(T ) and γ are the
transition rates. Unlike in [16], a constant α is intro-
duced (α = δ̄/β̄(1 + 10N)) to decouple the damage
rate from the vulnerable rate coefficient, so that three
distinct transition rates are considered to allow cells to
reach the vulnerable state. This diagram results in three
coupled ODEs (Eq. 3), solved with a first order explicit
scheme on the same grid and with the same time step
as the bioheat equation.

dU
dt
= −β(T )U + γV
dV
dt
= β(T )U − (γ + δ(T ))V
dN
dt
= δ(T )V
(3)
The property: U + V + N = 1 is also imposed at each
point. (Fig. 10, right) represents the solution of Eq. 3
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at one vertex over time if a constant temperature of
105◦C is applied.
For both heat transfer and cell death models, pa-
rameters are initially set to values from the literature [8]
reported in Table. 1, assumed similar for surrogate tu-
mor and hepatic tissue.
The cell death model is strongly coupled to the bio-
heat equation as the heat capacity depends on the state
of the cell (cUt , c
V
t and c
N
t correspond respectively to the
heat capacity of undamaged, vulnerable and necrotic
tissue) and the conductivity dt depends on the temper-
ature through dt = d̄t ∗ (1 + 1.61 ∗ (T − 310).10−3) as
in [8]. All the remaining parameters are constant.
Numerical Computation using LBM. Eq. 2 are
also solved using LBM with a MRT model. In RFA, it
has been used to compute heat transfer and validated
through a comparison with an analytical solution [9],
for a similar accuracy as FEM, though it has the ad-
vantage to be easily parallelized in GPU.
An isotropic Cartesian grid with 7-connectivity topol-
ogy has been found sufficient [9]. Neumann conditions
at the liver boundary defined as a level set function are
applied. For a time step of ∆t = 0.5 s and a spatial res-
olution of ∆x = 0.5 mm, better than real-time compu-
tation can be achieved on a desktop machine (Windows
7, Intel Xeon, 3.30GHz, 16GB RAM, 12 CPUs, Nvidia
Quadro K5000 4.0 GB). For example, it took around
10 mins to compute 17 mins of ablation of Pig 4-1.
Table 1 Nominal parameter values from the literature [8].
Notation Parameter Name Nominal
Tk (◦C) parameter of cell death
model
40.5
β̄ (s−1) damage rate coefficient 3.3×10−3
γ (s−1) recovery rate coefficient 7.7×10−3
δ̄ (s−1) vulnerable rate coefficient 3.3×10−3
cVt (J(kg K)
−1) heat capacity of vulnerable
tissue
3.6 ×103
cNt (J(kg K)
−1) heat capacity of necrotic tis-
sue
0.67×103
cUt (J(kg K)
−1) heat capacity of undamaged
tissue
3.6 ×103
d̄t (W(m K)−1) heat conductivity 0.512
R (W (m3K)−1) reaction coefficient 27.1×104
αv advection coefficient 0.11
3.3 Heating Power and Cooling Temperature
Computation
We assume that the equilibrium between probe and tis-
sue temperature is reached. During the heating period,
a Dirichlet boundary condition is used to fix the tem-
perature at the point sources of the probe tips: RFA is
simulated by imposing as input the temperatures mea-
sured at the five thermistors in a small neighborhood
around the probe tips: a layer of several voxels. Thus
simulating the source term Q from Eq. 2. The four re-
maining tip temperatures are linearly interpolated from
these values. Imposing temperature values does not pre-
vent of observing large temperature gradient next to
the tips. This large gradient of temperature is in fact
observed in our simulations. The heating stops at time
t = ta. During this period (t < ta) the heating power
can be computed, whereas the cooling temperature can
be computed when (t > ta).
Heating Stage. We assume that the measured power
is strongly correlated (proportional) to the heat power
P (t) delivered through radio-frequency to heat the liver
tissue. Proportionality is assumed to account for power
dissipation due to electrical resistance, and the unknown
surface ratio of the probe being heated, but also since
we do not model the heat loss by Joule effect. The heat
power P (t) delivered to the tissue can be computed at
each time step of the simulation from the bioheat equa-
tion according to Fourier’s law:
P (t) = α
∫
S
dt
∂T (t)
∂n
dS (4)
S is the probe surface, n is the outer normal at that sur-
face and α, the proportionality coefficient (α = 0.4469),
found by matching the peak value of the measured
power for Pig 1-1 with the peak value of the simulated
power with personalized parameters. This value is then
used in all the computations.
Cooling Stage. In the absence of any delivered heat
power, the nine tips of the probe cool down at a speed
which depends on the local conductivity dt and the heat
capacity ct. Thus, during the cooling period tc−ta (cool-
ing stops at time t = tc), the cooling temperature can
be simulated.
3.4 Parameter Estimation from Probe Measurements
During the intervention, the delivered power and the
temperature distribution are measured by the ablation
probe itself. We explore how these information can be
used to estimate apparent values of some model pa-
rameters. During the heating phase, the simulated heat
power Ps can be compared to the measured one Pm.
During the cooling phase, the simulated temperatures
Ts can be compared with the measurements Tm read
from five tips of the probe (four tips do not have any
thermistors).
In this study, the nominal parameters in the heat
transfer and cellular necrosis equation come from the
Comprehensive Pre-Clinical Evaluation of a Multi-physics Model of Liver Tumor Radiofrequency Ablation 9
literature. After a non reported sensitivity analysis, we
choose to estimate apparent values of the heat capac-
ity cUt and the constant part of the conductivity d̄t as
they mainly influence the delivered power, the temper-
ature distribution and the size of ablated regions. As
temperature maps are not readily available, these two
apparent values of the parameters are obtained by min-
imizing the following cost function:
arg min
cUt ,d̄t
(
1
ta
t=ta−∆tm∑
t=0
(Pm(t)− Ps(t))2
σ2Pm
+
1
tc − ta
tc∑
t=ta
(mTm(t)−mTs(t))2
σ2Tm
)
(5)
∆tm is the measurement time step, σPm and σTm are
the standard deviations associated with the heat power
and the temperature, both of them evaluated from the
variability in the available observations and equal to
13.3 W and 5.1 ◦C in our experiments. σPm acts as a
normalization factor in Eq. 5. It is computed from the
twelve ablations at one time point during the heating
phase (t = 50 s), time at which all power curves are
coherent (Fig. 11).
Fig. 11 Plot of the 12 delivered power curves for the first 200
seconds. The mean and standard deviation are computed at
t = 50 s, This time is a good compromise since it is not too
early, avoiding the boundary condition effect, and not too
late, before the cell death could affect the delivered power.
The wild fluctuations are due to the different heating/cooling
phases.
σTm is computed from the 5 temperature curves
extracted from the cooling phase of one ablation (Pig 1-
1), where all the temperature curves are coherent. We
did not use all the twelve ablations as their cooling stage
did not start at the same time. It is defined as follow:
σT
2
m =
1
tc
t=tc∑
t=ta
(
1
5
5∑
i=1
(Ti(t)−mT (t))2) mT (t) =
1
5
5∑
i=1
Ti(t)
To cope with the uncertainty in the rotation of the
probe along its axis, the mean tip temperature mT (t) is
used for the personalization instead of directly mapping
the tip temperatures.
4 Results
4.1 Evaluation of the Pre-processing
Evaluation of the Registration. The accuracy of the
registration is visually checked by an expert (Fig. 12).
Whenever available, the non-rigid transformation is ap-
plied to the post-operative vessel and/or tumor meshes
and they are compared to their pre-operative equivalent
meshes. Point-to-mesh errors from pre- to registered
post-operative meshes are computed for Pig 2 (Table 2).
Before the non-rigid registration, all the meshes are cen-
tered. The error is decreased after the registration ex-
cept for tumor 1 where the two meshes are already in
good agreement before the registration.
Before Registration 
After Registration 
Fig. 12 (Left) Superposition of the post-operative mesh
model in red on the pre-operative binary image; (Right) Com-
parison between the registered post-operative vessel meshes
in red (portal vein in thick, vena cava in thin lines) and the
pre-operative ones.
Evaluation of the Smooth Vessels Trees. In order
to evaluate the creation of the smooth vessels trees,
DICE, Positive Predictive Value (PPV) and sensitivity
scores between the original and the smoothed vessel
images are computed for Pig 4 (Table 3). They show a
good correlation between the original segmented vessels
and the generated ones.
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Table 2 Point-to-mesh errors from the pre- to the post-
operative meshes in millimeter before and after the registra-
tion for Pig 2. Before the registration, all the meshes are
centered.
Mesh Before registration After registration
hepatic veins 4.53 ± 2.13 2.30 ± 0.97
portal vein 6.13 ± 3.81 4.88 ± 4.38
arteries 21.34 ± 23.25 17.60 ± 19.71
tumor 1 2.25 ± 1.38 2.80 ± 1.49
tumor 2 8.80 ± 6.51 5.28 ± 4.50
liver 6.91 ± 3.57 3.53±1.60
Table 3 Dice, Positive Predictive Value (PPV) and sensitiv-
ity between the original and the smoothed vessel images for
Pig 4.
Mesh DICE (%) PPV (%) Sensitivity (%)
arteries 93.1 93.9 92.3
portal vein 91.3 85.3 98.3
hepatic veins 84.9 93.8 77.5
Verification of the CFD Solver on a Synthetic
Case. A cylindrical mesh with spherical inlet and outlet
(Fig. 13), is used to validate the CFD solver in the case
of a porous medium. Blood flow is set at the inlet and
pressure at the outlet. The flow entering the vessel Φin
should entirely go out: Φin = Φout, in the case of a
single vessel (case 1: Fig. 13, left) but also in the case
where the flow crosses a porous medium, a porosity map
is used to emulate two veins and the liver parenchyma
(case 2: Fig. 13, right). The porosity is set to 1 inside
the vessels, 0.04 in the endothelium and 0.1 outside.
The mass conservation is verified by comparing the flow
through the surface of the ”vessel” at z = 20mm: Φin
and at z = 80mm: Φout. In both cases, a difference
between these two fluxes of 3% is achieved.
φp p0 
Φin Φout 
(mm/s)            
Φin Φout 
20                    Z axis (mm)             80 100 
Case 1: vessel    Case 2: vessels + porous 
20             Z axis (mm)                    80 100 
Velocity Magnitude: 
Fig. 13 Synthetic case used to validate the CFD solver. (Top
Left) A cylindrical mesh with spherical inlet and outlet is
used. The boundary conditions are the inflow and the outlet
pressure. (Top Right) The velocity field given by the CFD
solver in the second case. (Bottom Row) The porosity field
used in the two cases.
4.2 Verification of the Parameter Estimation
Framework
As illustrated on Fig. 1, the framework enables param-
eter estimation too.
Synthetic Data Generation. In order to verify the
parameter estimation framework, we consider a syn-
thetic case on a simplified regular cuboid domain, to
speed-up the process (Fig. 14, left). As we try to esti-
mate the heat conductivity and the heat capacity, the
advection is not considered here.
We apply the typical clinical RFA protocol: during
three minutes, the temperature is increased linearly at
the tips of the probe to reach 105 ◦C, and then main-
tained for six minutes. Finally a cooling stage is ob-
served (no temperature imposed) for three more min-
utes. The extent of the necrotic area, delivered power
and temperature during the cooling stage are simulated
and then used as ground truth to estimate the parame-
ters: d̄t and ct by minimizing the cost function (Eq. 5).
Comparison of Optimization Methods. We com-
pare two gradient-free optimization methods available
in DAKOTA5: the Constrained Optimization BY Lin-
ear Approximations (COBYLA) and the pattern search
method (PS). Those methods are sequential trust-region
algorithms, therefore they do not rely on initial values,
but explore the whole domain of parameters in a first
stage. The range of parameters values used [7] are re-
ported in Table 4 and the other parameters are fixed to
the nominal values (Table 1).
First, a ground truth is considered using the values
of ct and d̄t found in Sec. 5 corresponding to healthy
swine tissue. Using COBYLA, we estimate the param-
eters with 0.8% error on d̄t and 0.6% on ct in 30 min-
utes after 22 iterations with a cost function value of
7.8 10−5 and a mean of the symmetric point-to-mesh
error of 10−4 mm. Similarly, using PS, we manage to
obtain the estimated parameters with 0.4% of error on
5 http://dakota.sandia.gov - multilevel framework for sen-
sitivity analysis.
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Fig. 14 (Left) Set-up of the synthetic case: the temperature
map around one tip of the probe, and the necrotic area (red)
created around the probe (dark). (Right) Convergence curves
of the COBYLA algorithm (blue) and of the pattern search
algorithm (green). The cost function is shown with respect to
the number of iterations.
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Notation Parameter Name Min - Max
cUt J(kg K)
−1 heat capacity of un-
damaged tissue
18 54
d̄t W(m K)−1 heat conductivity 0.256 0.768
Table 4 Ranges of parameters values explored in the opti-
mization framework.
d̄t, 0.3% on ct in 154 minutes after 117 iterations with
a cost function value of 7.2 10−6 and a similar mean
of the symmetric point-to-mesh error of 10−4 mm. The
convergence curves of both optimizations are shown on
(Fig. 14, right). We choose the COBYLA method to
perform the personalization as it requires less iterations
of the forward model to estimate the parameters with
similar accuracy as PS.
Evaluation. Cirrhotic tissue behaves like a thermal
insulator, preventing to heat outside the tumor tar-
geted for the ablation, leading to the so-called “oven
effect” [31]. In order to mimic this effect, the heat con-
ductivity is divided by two (to the best of our knowl-
edge, no value are reported in the literature) to generate
the ground truth, which differs from the one obtained
with the nominal value (Fig. 15, right). We manage to
find the correct cirrhotic value of d̄t (Fig. 15, left).
Simulated lesion with  
nominal parameters 
Simulated lesion with  
“cirrhotic” parameters 
Fig. 15 (Left) The parameter estimation framework leads to
the correct “cirrhotic” value of d̄t. (Right) The lesion obtained
with the “cirrhotic” d̄t in green is enclosed within the lesion
obtained with the nominal value in blue.
We verified on a synthetic case, that our method
allows to find ”cirrhotic” value of the heat conductivity
in the case of a diseased liver in the absence of noise
and model error.
4.3 Evaluation on Swine Data
We now evaluate our method on the available swine
data, whose liver tissues are healthy.
cooling heating 
Fig. 16 Temperature and delivered power evolution for Pig 1-
1. 3 different computations: with nominal parameters (green
curves), personalized parameters (red curves), and with ad-
vection (blue curves) are compared with actual measurements
(black curves). (Left) The error on the power evolution com-
puted over the heating phase is reduced from 19.9 to 7.5 W
after personalization and stays constant with advection (20.8
W). (Right) The error on the temperature evolution computed
over the cooling phase is reduced from 10.3 ◦C to 9.7 ◦C with
the advection, but stays constant after personalization (11.1
◦C). The advection clearly affects the temperature evolution.
During our experiments, the measured electrical power
appears consistently to reach its maximum during the
increase in temperature, before the plateau of 105◦C
(Fig. 16, left) in all cases. Given the considered model
and the Fourier’s law used to compute the delivered
power (Eq. 4), this phenomena cannot be explained by
a constant heat capacity which would lead to a peak
after the plateau is reached. Instead, following a non
reported sensivity analysis, we propose to adapt the
necrosis model of [16], so that the cells reach their vul-
nerable state faster, which is one way to explain this ob-
servation. By modifying δ̄, the two forward transitions
[U ]→ [V ] and [V ]→ [N ] are decoupled so that tissues
can reach very quickly their vulnerable state which en-
tails a significant change of ct (Table 5).
The model is evaluated on twelve ablations per-
formed on five swines (some swines have several sur-
rogate tumors). While the large and CT-visible hepatic
vessels have a cooling effect affecting the shape of the
thermal lesion [13], the effect of the hepatic perfusion
due to the small vessels non visible on CT images has
not been clearly identified so far. For this reason, the
simulations are performed without the advection term,
capturing the hepatic perfusion, except in Sec. 4.3.2 in
order to understand its effect on the necrotic lesion. By
keeping the reaction term, we only consider the heat
sink effect of the blood on the large visible vessels in
each simulation. The applied RFA protocol is not ex-
actly the same for all ablations. Eight ablations are
performed through several short cooling and heating
periods, whereas the other four ablations included only
one long final cooling stage after a continuous heating
period. For all pigs, nominal values of parameters (Ta-
ble 1) are employed. In each case, the simulated lesion
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is compared to the ground-truth. Fig. 17 shows results
for Pig 4-2.
Parenchyma 
Hepatic 
arteries 
Probe 
Portal 
vein 
Tumor 
Simulated  
lesion 
Post-op 
lesion Hepatic 
veins 
Tumor 
Fig. 17 (Left) The simulated lesion in yellow is showed
around the RFA probe in the subject-specific geometry on
Pig 4-2. (Right) A single orthogonal slice shows that the
simulated lesion is qualitatively close to the registered post-
operative lesion in brown: point-to-mesh error of 4.6 ±
3.9 mm. The color of the boxes correspond to the color of
the respective regions.
Quantitatively, symmetric point-to-mesh errors im-
plemented like in [32] computed between the simulated
lesion and the registered post-operative ground-truth
show suitable prediction of the necrotic extent (in red
on Fig. 18): average over all ablations of 5.3 ± 3.6 mm
of mean point-to-mesh error, smaller than the targeted
surrogate lesions diameter (around 2 to 3 cm), which
can be considered as sufficient for clinical applications.
Similarity scores averaged over all ablations are as fol-
lows: DICE: 44%, sensitivity: 47%, and PPV: 53% (in
red on Fig. 19). We achieve errors of 26 W and 5.1
◦C on average between measured and simulated values
of cooling temperature and delivered power (in red on
Fig. 20), which is good compared to the targeted abla-
tion temperature of 105 ◦C and the maximal power of
150 W.
4.3.1 Parameter Personalization
COBYLA is used to minimize the cost function (Eq. 5)
as only a few forward simulations (typically 20) are
required. As the data originates from healthy pigs of
similar age and weight, we hypothesize that their pa-
rameters would be similar too. The vulnerable rate co-
efficient is also adjusted to match the raise in delivered
power as detailed in Sec. 4.3. The minimization of the
error between measured and simulated values of power
and temperature is done only on two tumors with a long
final cooling stage (2 different Pigs: Pig 1-1 and Pig 4-3)
as it is long enough to observe reliably the effect of the
conductivity d̄t, yielding two sets of personalized val-
ues. The values independently found on the two swines
are really close: the same value of heat capacity cUt is
MEAN         S.D 
Fig. 18 Results for three different computations: with nom-
inal parameters, with personalized parameters and with the
advection term. For the computation with the advection
term, only 6 ablations are considered. Mean and standard
deviation of the point-to-mesh in mm computed on the sur-
face of the lesion.
DICE         SENSITIVITY              PPV 
Fig. 19 Similarity scores (DICE, Sensitivity and Positive
Predictive Value) in % computed on the volume of the le-
sion.
estimated, and the conductivity values are almost equal
to the nominal value as expected (Table 5). The esti-
mated parameters are then used on the ten remaining
cases to evaluate the discrepancy in terms of temper-
ature, delivered power and necrotic area. Small errors
were obtained in those cases too, without previously
having fit the parameters for those tumors. On aver-
age, the temperature and power errors are 7.8 ◦C and
20.4 W (in green on Fig. 20), the mean of the point-to-
mesh error is 6.0 mm (in green on Fig. 18) and similarity
scores are DICE: 42%, sensitivity: 43%, PPV: 55% as
illustrated in green on Fig. 19. Qualitatively, as one can
see on Fig. 21 (green curves), the simulated heat power
and temperature are close to the heat power and the
temperature given by the RFA probe itself. On aver-
age, the error is reduced after the use of personalized
parameters: from 35 W to 30 W and from 5.9 ◦C to
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Error on:     Power (W)                  Temperature (C) 
Fig. 20 (Left): Error computed during the heating phase on
the power in W (Right): Error computed during the cooling
phase on the temperature in ◦C.
1.9 ◦C. It is mainly reduced on the first heating period
(from 50 W to 27 W). During the cooling phase, the
simulated (non-imposed) temperature is compared to
the measured one, whenever measurement is available
(the RFA power was turned off during some cooling
phases).
Table 5 Comparisons between personalized and nominal val-
ues of estimated parameters.
Notation Nominal Personalized Values Automatic
Value on Pig 1-1 on Pig 4-3 optimisation
δ̄ 3.3×10−3 1×10−4 1×10−4 No
cUt 3.6 ×103 3.6 ×101 3.6 ×101 Yes
d̄t 0.512 0.614 0.512 Yes
4.3.2 Effect of the Advection
To quantify the effect of hepatic perfusion, the simula-
tions are performed by adding the advection term for
all pigs whenever it is possible to segment the vena cava
inlet (not possible for Pig 2 and 4). On average, the ef-
fect of the advection cannot be clearly highlighted. The
mean of the point-to-mesh error over the 6 ablations
computed with advection is 5.0 ± 3.5 mm (in blue on
Fig. 18), the average similarity scores are: Dice: 46 %,
sensitivity: 42 % and PPV: 53 % (in blue on Fig. 19). On
average, the error on the simulated power is 22 W and
4.7 ◦C on the temperature (in blue on Fig. 20). Those
values are comparable to the values obtained without
the advection term. As one can see on Fig. 21 (blue
curves), the errors remain constant with the advection
term (35 W and 6.3 ◦C). In some cases, the advection
reduces the error in term of necrotic extent and tem-
heating       cooling   h      c         h        c         h          c          h     
Fig. 21 Temperature and delivered power evolution for Pig 3-
1. 3 different computations: with nominal parameters (green
curves), personalized parameters (red curves), and with ad-
vection (blue curves) are compared with actual measurements
(black curves). During the heating phase, the temperature
is imposed: 5 temperatures are directly imposed from the 5
thermistors measurements (superposition of blue and black
curves) and the 4 remaining temperatures are imposed from a
linear interpolation from those measurements (4 blue curves).
The red curves are really similar to the blue curves, and they
can hardly be distinguished.
perature distribution (Pig 5-1), but not always (Pig 1-
1). The advection term always change the shape of the
necrotic extent (Fig. 22).
4.3.3 Effect of the Registration
One important part of the validation is the compari-
son of the simulated necrotic extent with a lesion seg-
mented on a post-operative image registered to the pre-
operative image. The modality of the post-operative im-
age is not always the same (CT or MR). The resolution
and the size of the post-operative image do not always
allow an accurate registration of the lesion, as for Pig 2-
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Fig. 22 Comparison between the simulated and the post-
operative necrotic areas on Pig 1-1. (Left) The post-op lesion
is showed around the RFA probe in the subject-specific geom-
etry. (Right) Single slice showing the simulated lesions with
(grey) and without (yellow) advection compared to the reg-
istered post-operative lesion (brown). The advection has an
effect on the shape of the lesion, however in this case, it does
not improve the point-to-mesh error: 6.9 ± 5.2 mm vs 4.8 ±
4.4 mm. The box colors correspond to the color of the regions.
2 (resolution: 0.78x0.78x4.8 mm, size: 384x384x36 mm).
To check the sensitivity of the computation to the reg-
istration, a new algorithm is used for this tumor only.
We rigidly translate the post-operative lesion so that
the barycenter of the post-operative lesion coincides
with the barycenter of the simulated necrotic extent
(Fig. 23, right). With this simple registration method,
the results are significantly improved. The lesion regis-
tration strongly affects the error measured between the
computed necrotic area and the ground truth.
Tumor 
Simulated  
lesion 
 
Post-op lesion after  
non-rigid registration 
 
Post-op lesion after  
matching barycenters 
 
Fig. 23 Effect of the registration on Pig 2 (Left) The post-
operative lesion after the non-rigid registration is showed in
the subject-specific geometry. The point-to-mesh error is 8.4
± 5.0 mm (Right) The post-op lesion after matching barycen-
ters. The point-to-mesh error reduces to 3.6 ± 2.9 mm.
4.3.4 Effect of the Probe Position
The position of the probe is known from an intra-operative
MRI. In some cases, the probe artifact and the image
contrast do not allow an accurate registration, as for
Pig 3-2. A new computation is performed for this tu-
mor to check the sensitivity of the computation to the
probe position. The same configuration is used except
that we manually put the probe inside the registered
post-operative lesion (position 2 in Fig. 24).
Position 1 
Position  
     2 
Position 2 Position 1 
Post-op 
lesion 
Simulated 
lesion 
Simulated 
    lesion 
Fig. 24 (Left) The post-operative lesion is showed around 2
possible positions for the RFA probe on Pig 3-2. (Right) Zoom
on the ablation area, the simulated lesion is closer to the reg-
istered post-operative lesion when the probe is in position 2,
point-to-mesh error of 6.2 ± 4.0 mm versus 12.6 ± 7.7 mm in
position 1.
With this probe position, the results are significantly
improved. The probe position affects the error mea-
sured between the computed necrotic area and the ground
truth (Fig. 24). It is equivalent to a registration er-
ror since by moving the probe, we move the computed
necrosis.
5 Discussion
We presented a first quantitative evaluation of RFA
computation, which combines a multi-physics model
and multi-modal medical images from a pre-clinical study.
Despite possible biases in the probe location and in es-
tablishing correspondences from the post- to the pre-
operative images due to registration errors, our model
provided new insights.
Hepatic  
arteries 
Portal 
 vein 
Hepatic  
veins 
Probe 
Simulated 
lesion 
Blood vessel 
Necrotic lesion 
Post-op 
lesion 
Fig. 25 (Left) The simulated necrotic extent around the RFA
probe, close to the border of the liver from Pig 3-3. The post-
operative lesion is shown in brown. (Right) The liver extrac-
tion confirms that the necrotic lesion is subcapsular.
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5.1 Model Limitations
The proposed model has several limitations. We as-
sume that tumor and healthy hepatic tissue have similar
properties. Experiments could be performed to assess
the effect of different spatial properties on the resulting
necrosis. The measured power is assumed to be propor-
tional to the power delivered through radio-frequency.
The Neumann boundary condition (no heat transfer
through the liver surface) may not be valid. If the ab-
lation location is subcaspsular (Pig 5-1, 4-1, 3-3), the
volume of the simulated ablation becomes larger, as the
heat bounces back on the border and increases artifi-
cially the heat diffusion inside the liver (Fig. 25). How-
ever, the liver has a high regulation capacity thanks
to its rich vascular system. If the heat is applied close
to the liver border, it is not clear how it dissipates,
whether or not it will affect the neighboring organs.
Moreover, the weak coupling between the heat transfer
model and the CFD model does not allow to consider
coagulation or the cessation of perfusion at temperature
above 60 ◦C, which is known to have a major impact
on ablation lesion size. However this type of coupling
due to coagulation has not been modeled so far by any
research team. Finally, during the RFA computation,
the temperature at the tips of the probe is imposed. It
would be more accurate to directly impose the delivered
power as in [33] and thus simulate the cooling as well as
the heating temperature distribution. This requires to
solve the spatio-temporal electromagnetic heating prob-
lem, adding more complexity to the model, whose im-
pact on the final thermal output is questionable and
difficult to validate. Moreover, this raises some techni-
cal issues as Neumann instead of Dirichlet boundary
condition would have to be applied.
5.2 Effect of the Registration
After several trials of registration algorithms, we were
able to reliably estimate in some cases, the deforma-
tion between pre- and post-operative imaging to evalu-
ate the necrosis extent prediction. But the registration
method uses only the liver surface, and two lesions are
poorly registered. However by taking the hepatic vessels
into account as well, the registration could be improved.
It should also be noted that the registration method dif-
fers from the one in [34], where the necrotic lesions were
registered rigidly to the pre-operative image by aligning
its barycenters which could introduce bias in the analy-
sis. The impact of those registration processes has been
evaluated on one tumor in this paper.
5.3 Towards Personalization
In clinical settings, due to the large variety of liver con-
ditions found during RFA (cirrhosis, fibrosis, etc), we
cannot assume inter-patient invariance of the biophys-
ical parameters, as done here for the five pigs. Param-
eter personalization is then required and the proposed
method may be suitable to get subject-specific param-
eters from easily accessible intra-operative quantities
(the probe temperature and delivered power). We pro-
posed a biophysical computational model whose com-
puting time, although already shorter than the real
physical process, remains too long to allow an easy use
in a well established clinical workflow. But an exten-
sive evaluation of such a comprehensive model is needed
before simplifications are made to reduce its complex-
ity and the invasive input data. The proposed method
could then be translated into clinical practice, as sev-
eral heating/cooling phases are generally necessary to
perform a complete ablation. The first heating/cooling
phase could be used to personalize the main parameters
of the model, which could then give a patient-specific
prediction of the lesion. Such a framework could help
the clinician during the intervention: the probe position
could be improved and/or the heating duration could be
adjusted if the simulated lesion does not cover entirely
the tumor for example. We evaluated the discrepancy
in terms of temperature and delivered power, and we
showed that key parameters can be estimated. This is a
proof of concept not only for the ability to personalize
the model but also for its predictive power by evaluat-
ing the simulation results on ten different tumors.
The necrotic extent is mainly controlled by the con-
ductivity d̄t and the heat capacity of vulnerable cells
cVt (not c
U
t ). d̄t was not changed after optimization, so
no significant difference in terms of necrotic area (mean
of the point-to-mesh error: 6.0 mm versus 5.3 mm on
average) or cooling temperature (error: 7.8 ◦C versus
5.1 ◦C) appeared after personalization, despite a better
match for the power (error: 20.4 W versus 25.9 W) as il-
lustrated on Fig. 16. Moreover, the point-to-mesh errors
were of the order of 5 mm; it suggests that simulations
with optimized d̄t and c
U
t might be realistic in terms of
necrotic area, power and temperature predictions.
The novel approach leads to an estimation of tem-
perature away from the probe at any time during the
ablation without requiring any information about the
necrotic regions. This additional information could be
used as surrogate to assess the amount and location of
damaged tissue during the intervention (cells receiving
excessive heat but without being necrosed) surrounding
the ablated region. Furthermore, as the probe temper-
ature and delivered power are available, in real-time,
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from the RF system, they could therefore be used for
therapy guidance, provided that heat transfer can be
computed much faster than real-time.
5.4 Pre-clinical Study Challenges
The pre-clinical validation approach was difficult to es-
tablish. It involves surrogate tumors implantation to
mimic the RFA current clinical practice, however the
surrogate tumors do not have any blood perfusion, and
we assumed that they have tissue properties similar
to hepatic tissue. It required acquisitions of different
modalities (CT, MRI, US), at different times (pre-, intra-
and post-operative images). The different images at Day
1 (day of intervention) should be acquired quickly, as
the anesthesia of the pig cannot last too long since
the pig will be kept alive for 2 additional days. Due
to the high complexity of the experimental set-up, pre-
processing is necessary. The segmentation was performed
semi-automatically, but the vessel meshes had to be
smoothed to avoid unstable solution of the CFD solver.
The probe was segmented from a CT image with a good
resolution, but the artifacts induced by the probe and
the bad resolution of the interventional MR images,
did not allow to accurately register the probe position.
The setting of subject-specific boundary conditions for
the blood flow and pressure was not straightforward,
since the acquisition process of Phase-Contrast MR im-
ages was complex to handle and requires a significant
learning curve. Due to the non reproducible and non-
coherent measures on the first four pigs, the measures
of blood flows and pressures of Pig 5 only were used in
all the computations.
Despite a comprehensive model and a complete pre-
clinical study for its validation, many sources of errors
are involved at the modeling level, but also at each pre-
processing step. We are not able to accurately locate
the position where the pressure was measured, but we
assume that there is no variation in pressure in a small
neighborhood of the two outlets. Even if the impact of
the segmentation process has to be taken into account,
we managed to identify most of the errors thanks to
the pre-clinical study. In a clinical setup, the use of an
invasive catheter to measure the pressure is not pos-
sible, neither the acquisition of Phase-Contrast MRI,
intra-operative MRI with the probe, injected CT with
the three different phases, which are not part of the
standard clinical workflow for RFA. Even if many of
the patient-specific parameters used in this study would
not be precisely available for each patient, this work is
a first step forward to get an insight on the most sensi-
tive parameters to be personalized and those which do
not affect the final output. A comprehensive biophysi-
cal model is therefore required for this evaluation. How-
ever, with a simplified blood flow model for example,
those measurements will not be required. Mathemati-
cal models can improve the current clinical practice by
providing more information to the clinician for the guid-
ance but also for the planning of the procedure. How-
ever, the questions of validation and error in the predic-
tions of such computational models are often neglected,
whereas it is absolutely key to their potential clinical
use. Having a model as detailed as possible is important
to fully evaluate the effects of the different biophysical
phenomena involved, and it is paramount to identify the
sources of errors. A study of the errors is a necessary
next step before using model-based therapy in clinical
routine. Knowing how the pre-processing errors (due to
segmentation, vessels smoothing, post-to-pre or probe
registration) propagate to the final computational out-
come would be of great interest. It would help to un-
derstand the modeling errors and to be more confident
on the resulting ablation. The validation could be im-
proved by acquiring images of better resolution, but this
would impact the well-being of animals in the current
framework.
6 Conclusion
In this paper, we presented a sophisticated pre-clinical
set-up to validate a complete multi-physics model of
RFA. This comprehensive validation was based on pre-
, intra-, post-operative images and device-based mea-
surements. The RFA computational model relies on LBM
and takes into account the main biophysical phenom-
ena (heat transfer, cellular necrosis, hepatic blood flow).
The advection effect of the porous circulation [11] is
considered by including a CFD model, robust to image
noise and anisotropy to compute the venous and arte-
rial blood flow in the liver parenchyma. We also showed
that parameter estimation is possible to reduce the bias
introduced by the use of nominal parameters. The ap-
proach was successfully evaluated on twelve ablations
from five swines, opening new opportunities for RFA
planning and guidance.
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